Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Avastin packs

FDA advised to halt Avastin breast cancer use

July 21, 2010
Sales and Marketing Roche, avastin

In a hammer blow to Roche, an influential Food and Drug Administration vote has gone against its cancer drug Avastin. …

News

Roche submits new version of Herceptin for US approval

July 7, 2010
Research and Development, Sales and Marketing Herceptin, Roche, breast cancer

Roche has submitted a new version of its blockbuster Herceptin (trastuzumab) to US regulators for approval to treat advanced breast …

News
Herceptin packs

NICE set to block Herceptin for gastric cancer

July 6, 2010
Sales and Marketing Herceptin, NICE, Roche, gastric cancer

NICE’s preliminary draft guidance has not approved Roche’s Herceptin for gastric cancer as it failed to show how far the …

News

Ovarian cancer trial boost for Avastin

July 5, 2010
Research and Development Roche, avastin, ovarian cancer

Roche’s blockbuster oncology drug Avastin has met its primary endpoint of improving progression-free survival in women with ovarian cancer in …

News

NICE thumbs up for Roche arthritis drug

July 2, 2010
Sales and Marketing NICE, RoActemra, Roche

NICE has given preliminary approval to Roche’s RoActemra as an additional option for the treatment of moderate to severe rheumatoid …

News
Tarceva

NICE rejects Tarceva maintenance treatment

June 17, 2010
Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer

Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …

News

Roche forms translational medicine research hub

May 26, 2010
Research and Development Roche, Switzerland, academic research, translational

Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what …

News

Roche discontinues arthritis drug trials

May 20, 2010
Sales and Marketing RA, Roche

Roche and Biogen Idec will discontinue clinical trials for rheumatoid arthritis drug ocrelizumab. Development of the RA treatment was halted …

News

India revokes Roche’s Valcyte patent

May 19, 2010
Sales and Marketing India, Roche, patents

Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …

News
Roche's China operations

Emerging markets lift Roche in Q1

April 16, 2010
Sales and Marketing Roche, emerging markets

Roche saw its sales grow 9% overall in the first quarter, with emerging markets medicines revenues showing a healthy 38% …

News

Roche buys insulin patch company

April 13, 2010
Research and Development Diagnostics, Roche, diabetes

Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market.  Medingo, formerly a …

News
RochePitzer

Frank Pitzer made chief executive at NimbleGen

April 7, 2010
Research and Development NimbleGen, Roche, appointment, research and development

Roche has promoted Dr Frank Pitzer to chief executive for its Madison, US headquartered genomics business NimbleGen. Dr Pitzer has …

Appointment

Roche’s Xeloda widens licence

April 1, 2010
Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer

Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …

News
RocheAttinger

Roche bags Siemens Healthcare coms head

March 25, 2010
Medical Communications Roche, appointment, medical communications, sales and marketing

Roche has appointed Stephen Feldhaus as its new head of group communications to succeed Per-Olof Attinger (pictured left), who moves …

Appointment

Roche delivers updated pipeline

March 18, 2010
Cancer, Roche

Roche says its pipeline can sustain its growth in oncology and increase its presence in personalised healthcare. Roche also plans …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025